SKB BIO (06990) subscribed 400 million yuan in Bank of China structured deposits.
Kelenbote Biotech (06990) announced that on August 4, 2026, the company entered into a structured deposit agreement III with Bank of China, under which the company agrees to subscribe to a structured deposit III with a principal amount of RMB 400 million.
SKB BIO (06990) announced that on August 4, 2026, the company entered into a structured deposit agreement III with Bank Of China, pursuant to which the company agreed to subscribe for a structured deposit III with a principal amount of RMB 400 million from Bank Of China.
Related Articles
Beijing UniStrong Science & Technology (002383.SZ) plans to publicly transfer 65% of its equity in Shanghai Titan.
SIPAI HEALTH (00314) has issued a positive profit forecast, expecting a net profit of 41 million to 44 million yuan in the first half of the year, achieving a turnaround from loss to profit year-on-year.
IPO News | Yundong Intelligent Resubmits Application to Hong Kong Stock Exchange as a Domestic Supplier of In-Vehicle Intelligent Connectivity Solutions
Beijing UniStrong Science & Technology (002383.SZ) plans to publicly transfer 65% of its equity in Shanghai Titan.
SIPAI HEALTH (00314) has issued a positive profit forecast, expecting a net profit of 41 million to 44 million yuan in the first half of the year, achieving a turnaround from loss to profit year-on-year.
IPO News | Yundong Intelligent Resubmits Application to Hong Kong Stock Exchange as a Domestic Supplier of In-Vehicle Intelligent Connectivity Solutions
RECOMMEND
